Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination
Latest in Blood
Plenary Papers
Jiarna R. Zerella; Claire C. Homan; Peer Arts; Xuzhu Lin; Sam J. Spinelli; Parvathy Venugopal; Milena Babic; Peter J. Brautigan; Lynda Truong; Luis Arriola-Martinez; Sarah Moore; Rachel Hollins; Wendy T. Parker; Hung Nguyen; Karin S. Kassahn; Susan Branford; Simone Feurstein; Lise Larcher; Flore Sicre de Fontbrune; Serwet Demirdas; Sonja de Munnik; Hélène Antoine-Poirel; Benedicte Brichard; Sahar Mansour; Kristiana Gordon; Marcin W. Wlodarski; Ashwin Koppayi; Sara Dobbins; Pim G. N. J. Mutsaers; Kim E. Nichols; Ninad Oak; Desiree DeMille; Rong Mao; Ali Crawford; Julie McCarrier; Donald Basel; Josue Flores-Daboub; Michael W. Drazer; Kerry Phillips; Nicola K. Poplawski; Graeme M. Birdsey; Daniela Pirri; Pia Ostergaard; Annet Simons; Lucy A. Godley; David M. Ross; Devendra K. Hiwase; Jean Soulier; Anna L. Brown; Catherine L. Carmichael; Hamish S. Scott; Christopher N. Hahn
Clinical Trials and Observations
Jennifer R. Brown; Barbara Eichhorst; Nicole Lamanna; Susan M. O’Brien; Constantine S. Tam; Lugui Qiu; Wojciech Jurczak; Keshu Zhou; Martin Šimkovič; Jiří Mayer; Amanda Gillespie-Twardy; Alessandra Ferrajoli; Peter S. Ganly; Robert Weinkove; Sebastian Grosicki; Andrzej Mital; Tadeusz Robak; Anders Osterborg; Habte A. Yimer; Megan Wang; Tommi Salmi; Liping Wang; Jessica Li; Kenneth Wu; Aileen Cohen; Mazyar Shadman

Advertisement intended for health care professionals

170,000 citations
earned in 2023


Featured Content

Comparing BTK inhibitors in relapsed/refractory CLL; unraveling the genetic background of the AnWj-negative blood type; rapid adaptation of CLL cells to venetoclax

Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype

Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE

Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesis

Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

TR4 and BCL11A repress γ-globin transcription via independent mechanisms

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals